Clinical utility of the FIB-4 index for predicting cardiovascular outcomes in patients with metabolic dysfunction-associated steatotic liver disease: a 10-year retrospective cohort study
Event: ESC Congress 2025
Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease
Session: Autoimmunity in focus
